| Singapore | English 中文 |
| Bangladesh | English |
| India | English |
| Indonesia | Bahasa English |
| Malaysia | English 中文 |
| Myanmar | English |
| Philippines | English |
| Sri Lanka | English |
| UAE | Arabic English |
| Vietnam | Tiếng Việt English |
Breast Cancer is a disease in which malignant (cancer) cells are detected in the tissues of the breast. These cells usually arise from the ducts or the lobules in the breast. These cancer cells can then spread within the tissue or organ and to other parts of the body.
Breast cancer is the most commonly occurring cancer in women and the second most common cancer overall. In Singapore, breast cancer is the most common cancer among women. It accounts for close to 30 per cent of the overall frequent cancer incidents in women between 2014 - 2018.* The highest incidence is in the 55 - 59 years age group. The risk of breast cancer increases with age. The good news is that more women are surviving the disease as a result of earlier detection and improved treatment.
*Source: Singapore Cancer Registry Annual Report 2018
There are several types of breast cancer, and they are differentiated by how the cancer cells look under the microscope (called histology); on whether the cancer cells have certain characteristics (receptor status); and on whether they are localised or have spread (stage).
In diagnosing breast cancer, doctors have to distinguish these types of breast cancer carefully so that they can recommend the most appropriate treatment plan for their patients.
This is the most common type of breast cancer and accounts for 70 to 80 per cent of all cases of invasive breast cancer. The cancer grows in the cells lining the milk ducts in the breast, which then break through the duct wall and invade the breast tissue around the area. These cells may also spread to other organs and parts of the body.
This is the non-invasive form of IDC, when the cancer does not spread to the surrounding breast tissue. It is also the most common type of non-invasive breast cancer. As it is non-invasive, DCIS is highly treatable, often with surgery alone. It should not be left untreated, however, as it can turn into invasive cancer and spread to other parts of the body.
About 10 per cent of breast cancers diagnosed are of this form of breast cancer, which tends to affect women between 45 and 55 years old. The cancer starts in the cells in the lining of the lobules, the glands that produce milk, and may spread to other parts of the body.
This non-invasive form of ILC is also known as lobular neoplasia. As LCIS shows no symptoms and cannot be seen with a mammogram, it is usually diagnosed during tests or spotted while treatment is being given for other breast conditions.
Seen in less than 1 per cent of all breast cancer cases, medullary breast cancer tends to hit women who have the inherent faulty BRCA1 gene. The cancer cells are bigger and there is usually a clear demarcation between the tumour and normal tissue.
Under the microscope, the cancer cells of this form of breast cancer look like tubes. Seen in about 2 per cent of all breast cancer cases, tubular carcinoma tends to affect older women in their 50s and above. It is usually diagnosed through a mammogram.
This aggressive and fast-growing form of breast cancer is seen in 1 to 5 per cent of all breast cancer patients. It can invade the skin and block lymph channels, which can cause redness, swelling and thickening of the overlying skin, and diffuse firmness of the breast.
Affecting 1 to 3 per cent of breast cancers, this slower-growing cancer tends to affect older women.
Paget disease of the nipple: This cancer, which accounts for 1 to 4 per cent of breast cancers, starts in the breast ducts and spreads to the nipple and the areola – the darker area of the skin around the nipple. It can irritate both and cause them to be scaly, itchy and red.
Breast cancers also have different biological characteristics, depending on the presence or absence of receptors such as estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). These characteristics also affect how the cancer behaves and how it needs to be treated – in some cases, even more than the histology of the cancer.
Most types of breast cancer (up to 70 per cent) are positive for ER or PR, or both. Such cancers tend to be slower-growing and less aggressive, and patients are, therefore, more likely to have a better long-term outcome. These cancers are usually treated with hormonal therapy such as tamoxifen and aromatase inhibitors.
Some 15 to 25 per cent of women are affected by HER2-positive cancer. This cancer arises when there are excess quantities of the human epidermal growth factor (HER2) protein – found on the surface of normal breast cells – thus causing cells to grow and divide abnormally.
This form of cancer does not have ER, PR, or HER2 receptors, and is usually aggressive. The rate of relapse is high, and survival rates are poor. Triple negative breast cancer accounts for about 15 per cent of breast cancers and tend to affect women under 40 and those with a faulty BRCA1 gene.
Studies have shown that the risk of getting breast cancer depends on a combination of factors. Having one or more risk factors does not mean you will get the cancer, but being aware of them can help you to take protective steps to reduce the risk. They include:
To confirm breast cancer, a biopsy will have to be performed in which cells or a piece of tissue is removed for examination under a microscope.
| Stages | Extent of Spread | Average 5-Year Survival Rate (%) | |
| 0 | Non invasive cancer | 99 | |
| I | Small invasive cancer | 90 | |
| II | Invasive cancer | 70 | |
| III | Large invasive cancer | 40 | |
| IV | Widespread or metastatic cancer | 20 |
In general, the larger the size of tumour the greater the chance of breast cancer reoccurring.
Histologic Grade: This refers to how much the tumour cells resemble normal cells when viewed under the microscope; the grading scale is 1 to 3. Grade 3 tumours contain rapidly growing cancer cells. The higher the histologic grade, the greater the chance of breast cancer relapsing.
The number of lymph nodes that is in the armpit, on the same side of the affected breast, is an important indicator. A higher number of positive nodes is associated with a worse outcome and warrants more aggressive treatments.
About two-thirds of all breast cancers contain significant levels of estrogen and/or progesterone receptors. They are referred to as estrogen receptor positive (ER+) tumours. ER-positive tumours tend to grow less aggressively and may respond favorably to treatment with hormones.
HER2 is a protein found on the surface of certain cancer cells. A tumour is described as being HER2-positive when it has a lot more HER2 receptors than others. About 20-25% of all breast cancers have tumours labelled HER2- positive. Tumours that are HER2-positive tend to grow more quickly than other types of breast cancer. By knowing if a cancer is HER2-positive can affect the choice of treatment because women with such tumour can benefit from anti Her2 targeted therapy.
Treatment options and prognosis (chance of recovery) depends on the stage of the cancer (whether it is in the breast only or has spread to other places in the body), the type of breast cancer, certain characteristics of the cancer cells and whether the cancer is found in the other breast. A woman’s age, menopausal status (whether a woman still has menstrual periods) and her general health can also affect treatment options and prognosis.
Most have surgery to remove the cancer. Forms of surgery include:
During both of the above breast surgeries, some of the lymph nodes under the same armpit will also be removed for examination.
Radiotherapy uses high-energy rays to target and kill cancer cells. The goal is to kill any cancer that might be left in or around the breast.
Radiotherapy is vital after a breast-conserving surgery like lumpectomy, since much of the breast tissue is left intact. It will lower the chances of the cancer returning in the breast.
Most women who have a mastectomy do not need radiotherapy. However, in some cases, it is used to treat the chest wall and the lymph nodes in the armpit, if the risk of local recurrence is determined to be high enough based on size and margin.
Screening usually involves checking your breasts for cancer even before there are any signs and symptoms. While screening cannot prevent breast cancer, it can help you to detect the cancer early, so that it can be treated earlier.
In general, screening tests include:
39 years and below |
|
40 to 49 years |
|
50 years and above |
|
You can reduce your risk through lifestyle choices such as maintaining a healthy weight by having a balanced diet, exercising regularly, limiting your intake of alcohol, and not smoking (or quitting if you smoke).
Read more at Breast Cancer Screening: Why bother?
You can take steps to monitor your breasts so as to be aware of any anomalies and changes through physical signs, screening tests and perform breast self-examinations.
Read more at Women's cancers: You can prevent them
Breast cancer may return despite the best care and treatment. When this happens, it is called a recurrence or relapse. A relapse may occur when some of the original cancer cells survive the initial treatment, or when cancer cells spread to other parts of the body while being undetected.
Some of the more common risk factors that may affect the chances of breast cancer returning include: